EPIPAGE2 Cohort Study Follow up at Five and a Half Years (EPIPAGE2)
Epidemiologic Study on Small-for-gestational-age Children (EPIPAGE2 Cohort Study) - Follow up at Five and a Half Years
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
A observational or N/A phase clinical study on Very Preterm Birth, this trial is completed. The trial is conducted by Institut National de la Santé Et de la Recherche Médicale, France and has accumulated 15 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
15 versions recorded-
Apr 16, 2026 — Present [daily]
Completed
-
Jan 2026 — Apr 2026 [monthly]
Completed
-
Sep 2025 — Jan 2026 [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
▶ Show 10 earlier versions
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Sep 2021 — Dec 2021 [monthly]
Completed
Status: Unknown Status → Completed
-
Jan 2021 — Sep 2021 [monthly]
Unknown Status
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status
-
Oct 2019 — Nov 2020 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jun 2018 — Oct 2019 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
May 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Sep 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
Epipage 2 (epidemiologic study on small-for-gestational-age children) is a nationwide study implemented to improve our knowledge of the outcome of preterm children in France. This study was launched on March 28, 2011 and includes three groups of preterm children, all born before 35 weeks: extremely preterm infants (born between 22 and 26 completed weeks of gestation), very preterm children (born between 27 and 31 completed weeks) and moderately preterm children (born between 32 and 34 completed weeks). These children are being studied from their birth up to the age of 12 years. At birth, data on maternal and infants' characteristics were collected from medical records. At one and two years, questionnaires sent to families and to physicians (at two years only) allowed to collect data about the children's life and health. At five and a half years, medical and psychological assessments are specifically implemented for the study in order to evaluate motor and cognitive disorders in this population.
Contact Information
- Institut National de la Santé Et de la Recherche Médicale, France
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Agen, France , Albi, France , Amiens, France , Angers, France , Arras, France , Auch, France , Basse-Terre, Guadeloupe , Bayonne, France , Beauvais, France , Besançon, France and 88 more locations